584 related articles for article (PubMed ID: 29980436)
1. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
2. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
4. CARD14
Manils J; Webb LV; Howes A; Janzen J; Boeing S; Bowcock AM; Ley SC
Elife; 2020 Jun; 9():. PubMed ID: 32597759
[TBL] [Abstract][Full Text] [Related]
5. Essential Role of CARD14 in Murine Experimental Psoriasis.
Tanaka M; Kobiyama K; Honda T; Uchio-Yamada K; Natsume-Kitatani Y; Mizuguchi K; Kabashima K; Ishii KJ
J Immunol; 2018 Jan; 200(1):71-81. PubMed ID: 29150564
[TBL] [Abstract][Full Text] [Related]
6. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
[TBL] [Abstract][Full Text] [Related]
7. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T; Polvere I; Voccola S; Vito P; Stilo R
Front Immunol; 2018; 9():2167. PubMed ID: 30319628
[TBL] [Abstract][Full Text] [Related]
8. CARD14/CARMA2sh and TANK differentially regulate poly(I:C)-induced inflammatory reaction in keratinocytes.
Voccola S; Polvere I; Madera JR; Paolucci M; Varricchio E; Telesio G; Porcaro P; Vito P; Stilo R; Zotti T
J Cell Physiol; 2020 Mar; 235(3):1895-1902. PubMed ID: 31486084
[TBL] [Abstract][Full Text] [Related]
9. MALT1 targeting suppresses CARD14-induced psoriatic dermatitis in mice.
Van Nuffel E; Staal J; Baudelet G; Haegman M; Driege Y; Hochepied T; Afonina IS; Beyaert R
EMBO Rep; 2020 Jul; 21(7):e49237. PubMed ID: 32343482
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
11. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
[TBL] [Abstract][Full Text] [Related]
12. Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.
Sundberg JP; Pratt CH; Silva KA; Kennedy VE; Qin W; Stearns TM; Frost J; Sundberg BA; Bowcock AM
Exp Mol Pathol; 2019 Oct; 110():104286. PubMed ID: 31323190
[TBL] [Abstract][Full Text] [Related]
13. Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cell Immunol; 2020 Aug; 354():104147. PubMed ID: 32593012
[TBL] [Abstract][Full Text] [Related]
14. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
15. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
16. PSORS2 is due to mutations in CARD14.
Jordan CT; Cao L; Roberson ED; Pierson KC; Yang CF; Joyce CE; Ryan C; Duan S; Helms CA; Liu Y; Chen Y; McBride AA; Hwu WL; Wu JY; Chen YT; Menter A; Goldbach-Mansky R; Lowes MA; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):784-95. PubMed ID: 22521418
[TBL] [Abstract][Full Text] [Related]
17. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways.
Guo H; Li M; Liu H
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231
[TBL] [Abstract][Full Text] [Related]
18. CARD14 expression in dermal endothelial cells in psoriasis.
Harden JL; Lewis SM; Pierson KC; Suárez-Fariñas M; Lentini T; Ortenzio FS; Zaba LC; Goldbach-Mansky R; Bowcock AM; Lowes MA
PLoS One; 2014; 9(11):e111255. PubMed ID: 25369198
[TBL] [Abstract][Full Text] [Related]
19. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan CT; Cao L; Roberson ED; Duan S; Helms CA; Nair RP; Duffin KC; Stuart PE; Goldgar D; Hayashi G; Olfson EH; Feng BJ; Pullinger CR; Kane JP; Wise CA; Goldbach-Mansky R; Lowes MA; Peddle L; Chandran V; Liao W; Rahman P; Krueger GG; Gladman D; Elder JT; Menter A; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):796-808. PubMed ID: 22521419
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]